References
- Sahlman P, Nissinen M, Pukkala E, et al. Incidence, survival and cause-specific mortality in alcoholic liver disease: a population-based cohort study. Scand J Gastroenterol. 2016;51:961–966.
- Testino G, Leone S, Borro P. Alcohol and hepatocellular carcinoma: a review and a point of view. World J Gastroenterol. 2014;20:15943–15954.
- Schuppan D. Liver fibrosis: common mechanisms and antifibrotic therapies. Clin Res Hepatol Gastroenterol. 2015;39:S51–S59.
- Anstee QM, Daly AK, Day CP. Genetics of alcoholic liver disease. Semin Liver Dis. 2015;35:361–337.
- Altamirano J, Bataller R, Cardenas A, et al. Predictive factors of abstinence in patients undergoing liver transplantation for alcoholic liver disease. Ann Hepatol. 2012;11:213–221.
- Edenvik P, Davidsdottir L, Oksanen A, et al. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice? Liver Int. 2015;35:1862–1871.
- IARC (WHO). IARC Monogr Eval Carcinog Risks Hum. 2012;100:377–503.
- Welzel TM, Graubard BI, Quraishi S, et al. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol. 2013;108:1314–1321.
- Heckley GA, Jarl J, Asamoah B, et al. How the risk of liver cancer changes after alcohol cessation: a review and meta-analysis of the current literature. BMC Cancer. 2011;11:446–450.
- Innes HA, Hutchinson SJ, Allen S, et al. Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from care. Hepatology. 2011;54:1547–1558.